Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Shares Issued (2016 - 2024)

Rocket Pharmaceuticals (RCKT) has disclosed Shares Issued for 7 consecutive years, with $321000.0 as the latest value for Q4 2024.

  • Quarterly Shares Issued rose 755.1% to $321000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $321000.0 through Sep 2025, down 88.7% year-over-year, with the annual reading at $3.2 million for FY2024, 45771.43% up from the prior year.
  • Shares Issued hit $321000.0 in Q4 2024 for Rocket Pharmaceuticals, up from $176000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $11.3 million in Q4 2021 to a low of -$9.9 million in Q3 2021.
  • Historically, Shares Issued has averaged $1.2 million across 4 years, with a median of $248500.0 in 2024.
  • Biggest YoY gain for Shares Issued was 37066.67% in 2021; the steepest drop was 990800.0% in 2021.
  • Year by year, Shares Issued stood at $2.6 million in 2020, then skyrocketed by 343.5% to $11.3 million in 2021, then crashed by 100.43% to -$49000.0 in 2023, then skyrocketed by 755.1% to $321000.0 in 2024.
  • Business Quant data shows Shares Issued for RCKT at $321000.0 in Q4 2024, $176000.0 in Q3 2024, and $1.5 million in Q2 2024.